We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Putting the Spotlight on Developability Platforms

Product News   Dec 10, 2019

 
Putting the Spotlight on Developability Platforms
FURTHER INFORMATION
 
 
 

Related Product News

Horizon Licenses Use of GS Knockout CHO K1 Cell Line to NGM Bio

Product News

Horizon has announced that it will license its gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster Ovary (CHO) K1 cell line to NGM Biopharmaceuticals.

READ MORE

ProBioGen and Lava Therapeutics Sign Development and Manufacturing Agreement for Novel Bispecific Molecule

Product News

ProBioGen and Lava Therapeutics have announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate.

READ MORE

Horizon Discovery to Provide Access to Novel Base Editing Technology

Product News

Horizon Discovery has announced that it will provide access to a novel base editing technology licensed from Rutgers for exclusive use in therapeutic, diagnostic and services applications.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE